Date: 2001-08-27
Help on accessing alternative formats, such as Portable Document Format (PDF), Microsoft Word and PowerPoint (PPT) files, can be obtained in the alternate format help section.
Contact
MDB
Health Products and Food Branch
Direction générale des produits de santé et des aliments
Therapeutic Products Directorate (TPD) and Biologics and Genetic Therapies Directorate (BGTD) posts safety alerts, public health advisories, press releases and other notices from industry as a service to health professionals, consumers, and other interested parties. Although TPD and BGTD approve therapeutic products, TPD and BGTD do not endorse either the product or the company. Any questions regarding product information should be discussed with your health professional.
This is duplicated text of a letter issued by the Therapeutic Products Directorate, Medical Devices Bureau.
Contact the company for a copy of any references, attachments or enclosures.
August 27, 2001
Dear Health Professional(s),
Several orthopedic manufacturers are recalling unimplanted Zirconia Ceramic Femoral Heads, specified as having been fabricated by Saint Gobain Advanced Ceramics Demarquest, France, after 1998. The reason for the recall is an increased rate of spontaneous fracture post-implantation.
You are advised as follows:
Do not implant Zirconia Ceramic Femoral Heads until the relevant manufacturer has confirmed which products are affected by the recall.
Return product affected by the recall to the relevant manufacturer.
Inform Health Canada of any cases of Zirconia Ceramic Femoral Head fractures by calling the Medical Devices Problem Reporting Hotline at 1-800-267-9675.
Recommendation:
Health Canada recommends that surgeons who have implanted Zirconia Ceramic
Femoral Heads from lots identified as being at higher risk of fracture,
inform their patients of the increased risk.
Discussion:
The French health authorities (AFSSAPS) have advised Health Canada of 61 reports of fracture of Zirconia ceramic femoral heads manufactured by St. Gobain Advanced Ceramics Desmarquest. The problem is believed to be due to a change in manufacturing process in 1998.
Failures are reported to have occurred between thirteen and twenty-seven months post-implantation at rates of up to 8.8% of implicated devices.
St. Gobain had supplied the affected zirconia ceramic heads to orthopaedic manufacturers supplying Canadian hospitals. These manufacturers are recalling affected products and have issued advice to hospitals in receipt of these products. Health Canada supports this action, and recommends that zirconia ceramic femoral heads supplied by these manufacturers not be implanted until the manufacturer has confirmed which products are affected by the recall.
This notice does not affect zirconia ceramic femoral heads supplied by other manufacturers not sourced from St. Gobain Advanced Ceramics Demarquest or femoral heads manufactured of alumina ceramic.
For further information, please contact the manufacturer of the device, or
original signed by
Beth Pieterson
Director, Medical Devices Bureau
beth_pieterson@hc-sc.gc.ca
Tel: 613 957-4786
Any suspected adverse incident can also be reported
to:
Health Products & Food Branch Inspectorate
HEALTH CANADA
Address Locator: 3002C
OTTAWA, Ontario, K1A 0K9
Tel: The Medical Devices Hotline 1-800-267-9675